NRX Pharmaceuticals (NRXP) Other Non Operating Income (2020 - 2024)
NRX Pharmaceuticals (NRXP) posted quarterly Other Non Operating Income of -$9000.0 for Q1 2024, down 175.0% year-over-year from $12000.0 in Q2 2023, and down 28.57% quarter-over-quarter from -$7000.0 in Q4 2023.
NRX Pharmaceuticals (NRXP) Other Non Operating Income (2020 - 2024) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Other Non Operating Income for 5 consecutive years, with -$9000.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Other Non Operating Income fell 175.0% year-over-year to -$9000.0; the TTM figure through Mar 2024 stood at -$1000.0 (down 100.91% YoY), while the FY2023 annual figure was $20000.0, down 92.16% from the prior year.
- Other Non Operating Income retreated to -$9000.0 in Q1 2024 per NRXP's latest filing, from -$7000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $17.4 million in Q2 2021 and bottomed at -$16.5 million in Q3 2021.
- Historically, Other Non Operating Income has averaged $198582.9 across 5 years, with a median of $15500.0 in 2022.
- Annual changes were most pronounced in 2021 — Other Non Operating Income jumped 981775.0% — and 2024, when it tumbled 175.0%.
- NRX Pharmaceuticals' Other Non Operating Income stood at $160.0 in 2020, then surged by 981775.0% to $1.6 million in 2021, then tumbled by 98.79% to $19000.0 in 2022, then plunged by 136.84% to -$7000.0 in 2023, then retreated by 28.57% to -$9000.0 in 2024.
- Business Quant data shows NRXP's Other Non Operating Income at -$9000.0 in Q1 2024, -$7000.0 in Q4 2023, and $26000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NRX Pharmaceuticals | 132.53 Mn | 105.83 Mn | 426,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -9,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 19,000.00 |
| Sep 30, 2022 | -37,000.00 |
| Jun 30, 2022 | 116,000.00 |
| Mar 31, 2022 | 157,000.00 |
| Dec 31, 2021 | 1.57 Mn |
| Sep 30, 2021 | -16.54 Mn |
| Jun 30, 2021 | 17.36 Mn |
| Mar 31, 2021 | 121,000.00 |
| Dec 31, 2020 | 160.00 |